Market Place
Sourcing Support
Orchard Pharma Receives Innovation Passport For OTL-201
01 May 2026 //
PHARMIWEB
Orchard Treats Last Patient in OTL-203 MPS-IH Trial
07 Jul 2025 //
GLOBENEWSWIRE
Orchard Therapeutics Appoints Robin As Chief Commercial Officer
12 Feb 2025 //
GLOBENEWSWIRE
Orchard Therapeutics Announces Data Presentations and Publications
23 Oct 2024 //
GLOBENEWSWIRE
Orchard And Er-Kim Partner For Libmeldy Access In Turkey
07 Oct 2024 //
GLOBENEWSWIRE
Orchard Therapeutics Announces Presentations At SSIEM 2024
28 Aug 2024 //
GLOBENEWSWIRE
Pharming Group uproots angioedema gene therapy collab with Orchard
09 May 2024 //
FIERCE BIOTECH
Pharming uproots angioedema gene therapy collab with Orchard
08 May 2024 //
FIERCE BIOTECH
Kyowa`s Orchard hopes $4.25M gene therapy price tag bears fruit
20 Mar 2024 //
FIERCE PHARMA
Orchard Announces First Patient Randomized in Registrational Trial of OTL-203
05 Feb 2024 //
GLOBENEWSWIRE
Orchard Therapeutics Announces Agreement with the Beneluxa Consortium
25 Jan 2024 //
GLOBENEWSWIRE
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics
24 Jan 2024 //
GLOBENEWSWIRE
Orchard Receives Swissmedic Approval for Libmeldy in Early-onset MLD
11 Dec 2023 //
GLOBENEWSWIRE
Orchard Receives U.S. FDA Fast Track Designation for OTL-203 in MPS-IH
30 Nov 2023 //
GLOBENEWSWIRE
Orchard Announces Presentation of Additional Positive Data from OTL-203
26 Oct 2023 //
GLOBENEWSWIRE
Orchard Therapeutics Announces Multiple Presentations at ESGCT 2023
24 Oct 2023 //
GLOBENEWSWIRE
Kyowa Kirin Buys Orchard for Potential $478M as FDA Decision Looms
06 Oct 2023 //
BIOSPACE
Orchard Therapeutics Announces Acceptance of BLA for OTL-200
18 Sep 2023 //
GLOBENEWSWIRE
Orchard Announces Data Comprising the Clinical Package for OTL-200 BLA in MLD
31 Aug 2023 //
GLOBENEWSWIRE
Orchard Therapeutics Completes Submission of BLA for OTL-200 in MLD to U.S. FDA
03 Aug 2023 //
GLOBENEWSWIRE
Orchard Supports Enactment of Newborn Metabolic Screening Act in Illinois
02 Aug 2023 //
GLOBENEWSWIRE
Orchard to Webcast Conference Call of Second Quarter 2023 Financial Results
25 Jul 2023 //
GLOBENEWSWIRE
Orchard Therapeutics Announces Second Closing of Strategic Financing
26 Jun 2023 //
GLOBENEWSWIRE
Orchard Therapeutics to Present at Stifel Genetic Medicines Day
24 May 2023 //
GLOBENEWSWIRE
Orchard Reports 1Q 2023 FYR Results of Rolling Submission forBLA of OTL-200
15 May 2023 //
GLOBENEWSWIRE
Orchard Therapeutics Announces New Clinical and Pre-clinical Data at ASGCT 2023
03 May 2023 //
GLOBENEWSWIRE
Orchard Announces Agreement Enabling Reimbursed Access to Libmeldy
27 Feb 2023 //
GLOBENEWSWIRE
Orchard Announces Presentation of Updated Integrated Analysis of OTL-200 in MLD
24 Feb 2023 //
GLOBENEWSWIRE
Orchard Highlights Progress Across HSC Gene Therapy Portfolio
09 Jan 2023 //
GLOBENEWSWIRE
Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203
05 Jan 2023 //
GLOBENEWSWIRE
